One Year of Medical Cannabis in the UK, Data by Grow Biotech - Seite 2

At present, it is only available on the NHS in extremely limited circumstances and is only obtainable through a prescription written by a specialist consultant in the private sector. NICE (The National Institute of Health Care Excellence) has advised that more clinical trials need to be undertaken in the UK and overall costs of medication need to be reduced before medical cannabis can be prescribed by NHS consultants. However, new medical trials are now underway and prices associated with the import of medical cannabis are falling dramatically, giving hope to the thousands of patients who are still struggling to access life-changing medication.

Another major change which cannot be overlooked is funding for the UK's young medical cannabis industry. Ben Langley, Chief Executive Officer of Grow Biotech explained that, "We have seen a massive increase in funding for UK businesses operating within the medical cannabis space, especially from North America. In addition to the £5m Grow Biotech has raised over the last two years, there have been notably well received fundraises for Emmac Life Sciences PLC (£11m raised in March 2019) and for Oxford Cannabinoid Therapeutics ($10m in April 2019). This trend is likely to accelerate as European medical cannabis gradually establishes itself as an attractive asset class for global capital and European equity exchanges start to open their doors to cannabis companies."

Both Ben Langley and Hari Guliani are available for comment and interview.

About Grow Biotech

Grow Biotech exists to unlock the medical potential of cannabis for those who need it.

Grow Biotech's market access team launches medical cannabis producers' businesses into new markets, creating long-term value for them. The company's R&D team creates new technologies for medical cannabis producers to create better, more cost-effective, medicines.

About IPS Pharma

IPS Pharma is a pharmaceutical importer, distributor and manufacturer with over 18 years' experience in unlicensed and licensed medicines.